Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1215 results found. Search for [ pharmaceutical companies ]

Results 1140 to 1160 of 1215
www.businesstoday.in
April 18, 2008
The small-cap universe is a treasure trove of bargains — provided you can spot them. We tie up with Trisys Research to identify stocks that aren't in the limelight, but have the potential to give high returns.


Dipen Sheth
March 19, 2008
Weighing the prospects of a US recession with continuing growth in developing countries, Dipen Sheth suggests investing in stocks with sustainable profits.


www.businesstoday.in
March 7, 2008
Read the impact on stocks of nine sectors that are likely to be most affected by the Budget proposals. We also list out some of the stocks in each sector that you might want to consider buying or selling.


Tanvi Varma/Money Today
January 23, 2008
Like IT, most pharma funds have underperformed in a booming market. What should the investor do right now — sell, hold or buy? Here are some answers.


Mudar Patherya
December 27, 2007
Don't scoff at this metal door fabrication company. Shakti Met-Dor supplies customised doors for use in IT, telecom, pharma and residential applications. And there’s a lot of growth in store.


Narayan Krishnamurthy and Devangshu Datta
December 12, 2007
We revisit India's most wanted stocks and find out which are the favourite stocks of fund managers and the hottest sectors they are investing your money in.


www.businesstoday.in
September 20, 2007
Enam Securities feels that most pharma companies will continue with lukewarm performance in 2007.


By Narayan Krishnamurthy
August 20, 2007
Sector equity funds allow investors to take a calculated gamble. But while the returns are higher than in a diversified fund, so are the risks.


By Rajshree Kukreti
August 8, 2007
Overcoming the dotcom bust, this husband-wife team persevered to make their software firm a success story.


www.businesstoday.in
March 22, 2007
The industry has hiked prices to pass on a dual-rate excise hike. Earnings will dip 15% without the hike.


By Devangshu Datta
March 22, 2007
There is still scope for growth in stock prices, but don’t expect your portfolio to go ballistic in 2007.


Anumeha Chaturvedi
July 22, 2010
After a successful outing in China, some of the world's biggest skincare brands are hoping for an encore in India.


E. Kumar Sharma
July 22, 2010
Multinationals are closing in on Big Pharma, but there are enough mid-size stars as well.


Shalini S. Dagar
July 6, 2010
Two years after it slammed into a US regulatory wall, Ranbaxy Laboratories, under its Japanese owners, is working the hard way to be back among the stars.


E. Kumar Sharma
June 9, 2010
Piramal's domestic formulations business becomes the latest—and most expensive—acquisition of an Indian drug business by a global pharma major. As the stakes get higher, who's next?


www.businesstoday.in
March 31, 2010
The Medical Council cracks the whip on the nexus between pharma companies and doctors.


T.V. Mahalingam and Kushan Mitra
March 2, 2010
Ten years ago this month, the dotcom bust began, burning trillions of dollars and millions of dreams. BT asks two entrepreneurs who were there for the lessons they learnt.


Vikram Chhachhi
February 2, 2010
The authors make an honest attempt to explain how companies should manage their most gifted and intelligent people. However, the book falls short on several counts.


K.R. Balasubramanyam and Josey Puliyenthuruthel
February 2, 2010
Started as Minnesota Mining and Manufacturing Company in 1902, 3M, as it is known today, has been the subject of many a case study in business schools for its culture of innovation.


Herminia Ibarra & Otilia Obodaru
November 15, 2009
Women are judged to be less visionary than men in 360-degree feedback. It may be a matter of perception, but it stops women from getting to the top.


PAGES 58 OF 61  5657585960